| Literature DB >> 25888078 |
Daniel Alexandre Bottino1, Flávia Gomes Lopes2, Francisco José de Oliveira3, Anete de Souza Mecenas4, Ruth Clapauch5, Eliete Bouskela6.
Abstract
BACKGROUND: There is a functional decline of endothelial- dependent vasodilatation in the aging process. The aims of this study were to investigate if various microcirculatory parameters could correlate to anthropometrical variables, oxidative stress and inflammatory biomarkers in successful aging and compare the results to young healthy controls.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25888078 PMCID: PMC4393601 DOI: 10.1186/s12877-015-0044-x
Source DB: PubMed Journal: BMC Geriatr ISSN: 1471-2318 Impact factor: 3.921
Subjects clinical and laboratorial data
|
|
|
| |
|---|---|---|---|
| Age | 23.1 ± 3.6 | 74.0 ± 8.7* |
|
| Body mass index (kg/m2) | 21.7 ± 2.1 | 24.5 ± 3.9* |
|
| Waist to hip ratio | 0.73 ± 0.04 | 0.83 ± 0.06* |
|
| Systolic BP, mmHg | 108 ± 11 | 128 ± 17* |
|
| Diastolic BP, mmHg | 69 ± 8 | 69 ± 11 | 0.738 |
| Heart Rate , bpm | 65 ± 8 | 70 ± 10 | 0.650 |
| Fasting glucose, mg/dl | 81 ± 8 | 89 ± 4* |
|
| Fasting insulin, μUI/ml | 7 ± 3 | 6 ± 3 | 0.614 |
| Postload Plasma Glucose, mg/dl | 99 ± 20 | 125 ± 18* |
|
| HOMA-IR | 1.44 ± 0.68 | 1.38 ± 0.62 | 0.729 |
| Total cholesterol, mg/dl | 172 ± 27 | 187 ± 30* |
|
| HDL cholesterol, mg/dl | 68 ± 16 | 66 ± 17 | 0.717 |
| LDL cholesterol, mg/dl | 89 ± 17 | 109 ± 14* |
|
| Non-HDL cholesterol, mg/dL | 104 ± 17 | 129 ± 19* |
|
| Triglycerides, mg/dl | 67 ± 26 | 104 ± 37* |
|
| Fibrinogen mg/dl | 265 ± 50 | 340 ± 21* |
|
BP = blood pressure. *p <0.05 or p <0.01 related to Young Controls. Reference values: Fasting glucose <99 mg/dl; fasting insulin <13μUI/ml; Post load plasma glucose <140 mg/dl; Total cholesterol <240 mg/dl; triglycerides <150 mg/dl; high density lipoprotein (HDL-cholesterol) >40 mg/dl), respectively. Low density lipoprotein (LDL-cholesterol) was calculated using Friedewald’s equation17 using as reference value <130 mg/dl. Glucose and insulin levels were measured by enzymatic-colorimetric without pretreatment (reference value <99 mg/dl) and automated chemiluminescent methods (reference value <13μUI/ml), respectively. Homeostasis model assessment of insulin resistance (HOMA-IR) index was calculated as fasting insulin (mU/l) x fasting glucose/22.5 (reference value 2.1 ± 0.7)24. High-sensitivity C-reactive protein determination was obtained by nephelometry method (reference value <0.5 for inflammatory process and < 0.11 for cardiovascular risk assessment). Fibrinogen was determined by coagulometric method (reference values between 200 and 400 mg/dl).
Inflammatory and oxidative stress biomarkers
|
|
| ||
|---|---|---|---|
| sVCAM (ng/ml) | 19.3 [16.7-21.9] | 29,7 [25-35]* |
|
| sICAM-1 (ng/ml) | 9.8 [9.3-11.2] | 11.5 [9.7-13.6] | 0.057 |
| sE-SELECTIN (ng/ml) | 2.2 [1.1-3.1] | 2.6 [2.4-3.4]* |
|
| Oxidized – LDL (mU/l) | 35449 [31138-41238] | 43909 [42154-47075]* |
|
| IL-1 beta (pg/ml) | 0.4 [0.2-0.7] | 0.3 [0.1-0.6] | 0.515 |
| IL-6 HS (pg/ml) | 2.2 [1.5-5.4] | 2.2 [1.1-2.9] | 0.879 |
| TNF-alpha (pg/ml) | 1.8 [1.5-3.3] | 1.8 [1.38-2.40] | 1.000 |
| hS C-reactive protein, mg/dl (mg/dl) | 0.30 [0.07-0.59] | 0.44 [0.23-0.63] | 0.584 |
sVCAM= soluble Vascular Cell Adhesion Molecule; sICAM= soluble Intercellular Adhesion Molecule; sE-SELECTIN = soluble endothelial selectin; IL-1 beta = Interleukin-1 beta; IL-6 HS = Interleukin-6 High Sensitivity; TNF-alpha = Tumor Necrosis Factor–alpha. *p < 0.05 related to Young Controls.
Microcirculatory evaluation (NVC) and vasoreactivity analysis (VOP)
|
|
|
| |
|---|---|---|---|
|
| 13.6 [12.6-14.9] | 12.8 [11.9-13.7] | 0.100 |
| AFD (μm) | 8.5 [6.1-11.2] | 15.4 [13.7-16.3]* |
|
| APD (μm) | 8.7 [7.1-10.7] | 15.3 [13.6-17.0]* |
|
| EFD (μm) | 8.7 [7.2-12.0] | 14.9 [14.3-16.2]* |
|
| RBCVbasal | 0.24 [0.22-0.28] | 0.29 [0.29-0.30]* |
|
| RBCVmax | 0.35 [0.33-0.39] | 0.35 [0.34-0.36] | 0.616 |
| RBCVmax/RBCVbas | 1.35 [1.21-1.79] | 1.23 [1.17-1.26]* |
|
| Time to reach RBCVmax/RBCVbas (s) | 5 [4-6] | 4 [4-6] | 0.408 |
|
| |||
| % Hyper | 606 [508-744] | 316 [256-465]* |
|
| % Nitro | 208 [122-257] | 187 [130-202] | 0.530 |
FCD = Functional Capillary Density; Afferent, Apical and efferent capillary diameters (AFD,APD and EFD); RBCVmax/RBCVbas = increment of maximum red blood cell velocity (RBCVmax) related to RBCV at baseline; % Hyper = percent of increment of forearm blood flow during reactive hyperemia related to baseline; % Nitro = increment of forearm blood flow after sublingual spray of nitroglycerine related to baseline. *p < 0.05 or p < 0.01 related to young controls.
Figure 1Capillary diameters seen on Nailfold Videocapillaroscopy in the elderly and young controls groups. Note that old people with healthy aging present larger capillaries than young controls (*p < 0.05).
Figure 2Spearman correlations between fibrinogen (A), LDL-cholesterol (B), oxidized-LDL-cholesterol (C), sVCAM (soluble Vascular Adhesion Molecule) (D) and %Hyper (percent of increment of forearm blood flow during the reactive hyperemia related to baseline). Box E shows Spearman correlation between sVCAM and RBCVmax/RBCVbaseline (increment of maximum red blood cell velocity related to baseline values).